Hot Pursuit     04-Jul-24
Sun Pharmaceuticals Industries Ltd rises for third consecutive session
Sun Pharmaceuticals Industries Ltd is quoting at Rs 1558.7, up 1.61% on the day as on 12:49 IST on the NSE. The stock is up 49.2% in last one year as compared to a 25.55% spurt in NIFTY and a 46.49% spurt in the Nifty Pharma index.

Sun Pharmaceuticals Industries Ltd gained for a third straight session today. The stock is quoting at Rs 1558.7, up 1.61% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Sun Pharmaceuticals Industries Ltd has risen around 4.8% in last one month.

Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has risen around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 11.37 lakh shares today, compared to the daily average of 22.61 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1557.85, up 1.61% on the day. Sun Pharmaceuticals Industries Ltd is up 49.2% in last one year as compared to a 25.55% spurt in NIFTY and a 46.49% spurt in the Nifty Pharma index.

The PE of the stock is 120.96 based on TTM earnings ending March 24.

Previous News
  Market extends record rally for 2nd day; VIX slides 2.65%
 ( Market Commentary - Quick Review 04-Jul-24   15:58 )
  European Medicines Agency validates submission of MAA for Nidlegyâ„¢
 ( Corporate News - 04-Jul-24   15:04 )
  Sun Pharma gains on EMA nod for Nidlegy
 ( Hot Pursuit - 04-Jul-24   14:18 )
  Sun Pharmaceuticals Industries Ltd rises for third consecutive session
 ( Hot Pursuit - 04-Jul-24   13:05 )
  Sun Pharmaceuticals Industries Ltd Slides 0.84%
 ( Hot Pursuit - 03-Jul-24   09:30 )
  Sun Pharma completes acquisition of Taro
 ( Corporate News - 24-Jun-24   18:05 )
  Nifty below 23,500; European market declines
 ( Market Commentary - Mid-Session 21-Jun-24   13:34 )
  Broader mkt rallies; IT shares in demand
 ( Market Commentary - Mid-Session 21-Jun-24   10:32 )
  Sun Pharma enters into patent licensing agreement with Takeda
 ( Corporate News - 21-Jun-24   09:30 )
  Sun Pharma inks agreement with Takeda Pharma for commercialising Vonoprazan tablets in India
 ( Hot Pursuit - 21-Jun-24   09:26 )
  Sun Pharmaceuticals Industries to convene AGM
 ( Corporate News - 20-Jun-24   17:14 )
Other Stories
  PEL board OKs ad hoc appointments post Rupen Patel's passing
  06-Jul-24   16:41
  Info Edge Q1 FY25 billings climb 11% YoY
  06-Jul-24   15:50
  IndusInd Bank advances climb 16% YoY in Q1 FY25
  06-Jul-24   15:18
  Adani Wilmar reports 13% volume growth in Q1 FY25
  06-Jul-24   14:44
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
Back Top